Friday, November 4, 2022
The tenure of our president and CEO, Dr. Thierry Mesana will conclude in March 2024. The Institute’s by-laws stipulate the selection process for a new CEO should commence two years ahead of the end of the current mandate. The Institute will begin a new chapter in its storied history of excellence in cardiac research, education, and care.
Dr. Mesana’s exceptional leadership, both as Chief of Cardiac Surgery and later as president and CEO, has made a profound impact; his legacy, meaningful and everlasting is the perfect foundation for anyone suited to fill this critical and significant role.